Month: August 2022

Alpine Income Property Trust Increases Quarterly Dividend By 1.9% and Declares Dividend For the Third Quarter 2022

Written by Customer Service on August 22, 2022. Posted in Dividend Reports And Estimates.

WINTER PARK, Fla., Aug. 22, 2022 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that its Board of Directors has authorized, and the Company has declared a quarterly cash dividend of $0.275 per share of common stock for the third quarter of 2022 (the “Common Stock Cash Dividend”), which represents a 1.9% increase as compared to the Company’s previous quarterly cash dividend of $0.27 per share of common stock. The Common Stock Cash Dividend represents a 7.8% year-over-year increase as compared to the Company’s third quarter 2021 common stock cash dividend and an annualized yield of approximately 6.0% based on the closing price of the common stock on August 19, 2022. The Common Stock Cash Dividend is payable on September 30, 2022 to stockholders of record as of the close of business...

CTO Realty Growth Increases Quarterly Dividend By 1.8% and Declares Dividends For the Third Quarter 2022

Written by Customer Service on August 22, 2022. Posted in Dividend Reports And Estimates.

WINTER PARK, Fla., Aug. 22, 2022 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) announced today that its Board of Directors has authorized, and the Company has declared a quarterly cash dividend of $0.38 per share of common stock for the third quarter of 2022 (the “Common Stock Cash Dividend”), which represents a 1.8% increase as compared to the Company’s previous quarterly cash dividend of $0.37333 per share of common stock. The Common Stock Cash Dividend is being increased to account for the Company’s strong year-to-date cash flow growth and the need to distribute a certain amount of taxable income to maintain its REIT tax status. The Common Stock Cash Dividend represents a 14.0% year-over-year increase as compared to the Company’s third quarter 2021 common stock cash dividend and an annualized...

Supplementary prospectus to £3,000,000,000 Euro Medium Term Note Programme

Written by Customer Service on August 22, 2022. Posted in Public Companies.

Issuer LEI: 213800ZBKL9BHSL2K459 OSB GROUP PLC (the “Company” or “Issuer”) The Company announces today that a supplementary prospectus dated 22 August 2022 to the base prospectus dated 14 January 2022 (the “Base Prospectus“), as supplemented on 1 April 2022, in relation to the establishment of its £3,000,000,000 Euro Medium Term Note Programme (the “EMTN Programme”) has been approved by the Financial Conduct Authority and is available for viewing. To view the full document, paste the following URL into the address bar of your browser: https://www.osb.co.uk/investors/bond-investors/emtn-programme A copy of the EMTN Programme will also be submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism. OSB GROUP PLC Alastair Pate t:...

Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes

Written by Customer Service on August 22, 2022. Posted in Public Companies.

Bagsværd, Denmark, 22 August 2022 – Novo Nordisk today announced headline results from a phase 2 clinical trial with CagriSema, a once-weekly subcutaneous combination of semaglutide and a novel amylin analogue, cagrilintide. The trial investigated the efficacy and safety of a fixed dose combination of CagriSema (2.4 mg semaglutide and 2.4 mg cagrilintide) compared to the individual components semaglutide 2.4 mg and cagrilintide 2.4 mg, all administered once weekly, in 92 people with type 2 diabetes and overweight. People were equally randomised among the three treatment arms. In the trial, the mean baseline HbA1c was 8.4% and the mean baseline body weight was 106 kg. After 32 weeks of treatment, people treated with CagriSema achieved a numerically higher HbA1c reduction of 2.18%-points compared to a reduction of 1.79%-points for people...

Parsons to Present at Raymond James Diversified Industrials Conference

Written by Customer Service on August 22, 2022. Posted in Public Companies.

CENTREVILLE, Va., Aug. 22, 2022 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that Carey Smith, chair, president, and chief executive officer, and Matt Ofilos, chief financial officer, will present at the 2022 Raymond James Diversified Industrials Conference in New York City on Tuesday, August 23, 2022, at approximately 8:35 a.m. Eastern Time. This presentation will be available live via webcast on the investor relations section of Parsons’ website (https://investors.parsons.com/). A replay of the webcast also will be available on the website for 30 days. About Parsons Parsons (NYSE: PSN) is a leading disruptive technology provider in the national security and critical infrastructure markets, with capabilities across cybersecurity, missile defense, space, C5ISR, transportation, environmental remediation, and...

Assure Holdings Corp. Prices $6.2 Million Underwritten Public Offering of Common Stock

Written by Customer Service on August 22, 2022. Posted in Public Companies.

DENVER, Aug. 22, 2022 (GLOBE NEWSWIRE) — Assure Holdings Corp. (NASDAQ: IONM) (“Assure Holdings” or the “Company“), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced the pricing of an underwritten public offering with gross proceeds to the Company expected to be approximately $6.2 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The offering equates to 5,576,087 shares at a price to the public of $1.12 per share. The Company intends to use the net proceeds from this offering for general corporate purposes, including, but not limited to, repayment of indebtedness and increasing working capital expenditures. In addition, the Company granted the underwriters a 45-day option to purchase additional shares of...

Aurora Spine Corporation Schedules Release of Second Quarter Fiscal Year 2022 Financial Results and Conference Call

Written by Customer Service on August 22, 2022. Posted in Public Companies.

CARLSBAD, Calif., Aug. 22, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial results press release for the second quarter ended June 30, 2022, on Monday, August 29, 2022. Management will host a conference call that day at 11:00 a.m. Eastern Time to discuss the results. Second Quarter 2022 Conference Call Details Date and Time: Monday, August 29, 2022, at 11:00 a.m. ET Call-in Information: Interested parties can access the conference call by dialing (844) 861-5497 or (412) 317-5794. Webcast: Interested parties can access the conference call via a live webcast, which is available via the following link: https://app.webinar.net/0617xnKbZaA...

Industrial Wood Pellet Market Size to Hit USD 7.69 Billion by 2027 | Exhibit a CAGR of 8.56%

Written by Customer Service on August 22, 2022. Posted in Mergers And Acquisitions.

Increasing Adoption of Biofuels among Industries to Propel Growth of Global Industrial Wood Pellet Industry Pune, India, Aug. 22, 2022 (GLOBE NEWSWIRE) — According to Fortune Business Insights, the global industrial wood pellet market size is projected to hit USD 7.69 billion by 2027 and exhibit a CAGR of 8.56% during the forecast period. The market size stood at USD 5.54 billion in 2019 and USD 4.33 billion in 2020. The industrial wood pellet market set to flourish stoked by the increased demand for clean energy. Industrial Wood Pellet market to gain traction from stringent government initiatives promoting biofuels for energy production. Industry Developments: In October 2018, Pinnacle Renewable Holdings Inc. announced that it had completed the acquisition of a 70% share in an industrial wood pellet production facility located...

Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

Written by Customer Service on August 22, 2022. Posted in Public Companies.

CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) today announced the publication of an article entitled “Reduction in the Risk of Major Adverse Cardiovascular Events with the BET Protein Inhibitor Apabetalone in Patients with Recent Acute Coronary Syndrome, Type 2 Diabetes, and Moderate to High Likelihood of Non-Alcoholic Fatty Liver Disease” in the American Journal of Preventive Cardiology. The article presents a post-hoc analysis of BETonMACE data, which demonstrates apabetalone treatment improves cardiac outcomes and liver fibrosis scores in patients with moderate-to-high likelihood of advanced liver fibrosis. The article is published online HERE. “In this patient group, apabetalone treatment was associated not only with fewer negative cardiovascular outcomes, but also...

Teleflex to Expand Its Surgical Portfolio with Differentiated Stapling Technology for Bariatric Surgery

Written by Customer Service on August 22, 2022. Posted in Mergers And Acquisitions.

Signs Definitive Agreement to Acquire Standard Bariatrics WAYNE, Pa., Aug. 22, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has entered into a definitive agreement to acquire Standard Bariatrics, Inc. which has commercialized an innovative powered stapling technology for bariatric surgery. Under the terms of the agreement, Teleflex will acquire Standard Bariatrics for an upfront cash payment of $170 million at closing, with additional consideration of up to $130 million payable upon the achievement of certain commercial milestones. The acquisition is subject to customary closing conditions, including receipt of certain regulatory approvals, and is expected to be completed early in the fourth quarter of 2022. The Titan SGS® from Standard Bariatrics...

Month: August 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals